Search | Result
| ID | 3638 |
|---|---|
| Class | Mammalia |
| Species | Homo sapiens |
| Tissue | NA |
| Sample | Tissue |
| Disease type | Neuroblastoma |
| Cell type | Tumor cells |
| Cell type (subtype) | Resistant cells |
| Cell marker | PKIB, NEUROD4, PLP1, CER1, PTX3, INHBE, MYL1, SIX1, RPRM, BORIS, KCTD8, CEBPD, ARHGAP36, DACT1, RBM24, NEUROD1, NEUROG1, INSM1, KLHL1, SI2 |
| Frequency | |
| PubMed ID | 31391581 |
| Journal | Nature |
| SCI IF | 49.962 |
| Evidence | Fig. 1b by upregulation of BORIS, ultimately leading to a fully resistant state in which BORIS expression was highest and detectable in essentially all cells |
| Title | BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells |
| Authors | David N Debruyne et al. |
| Date | 2019.8 |
| Data available | GSE103086 |
